-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Amicus Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2019 to 2024.
- Amicus Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 308M shares, a 1.48% increase year-over-year.
- Amicus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 304M shares, a 3.12% increase from 2023.
- Amicus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 295M shares, a 2.11% increase from 2022.
- Amicus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 289M shares, a 6.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)